NDUFAF2 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 2 | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |
PPWD1 | Peptidylprolyl isomerase domain and WD repeat containing 1 | Enzymes
| | | | | Expressed in all |
NLN | Neurolysin (metallopeptidase M3 family) | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
CD180 | CD180 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CENPH | Centromere protein H | | | | | | Mixed |
MRPS36 | Mitochondrial ribosomal protein S36 | Mitochondrial proteins
| | | | | Expressed in all |
CDK7 | Cyclin-dependent kinase 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
TAF9 | TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa | Enzymes Plasma proteins
| | | | | Expressed in all |
RAD17 | RAD17 homolog (S. pombe) | | | | | | Expressed in all |
MARVELD2 | MARVEL domain containing 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
SMN2 | Survival of motor neuron 2, centromeric | Disease related genes
| | | | | Expressed in all |
MCCC2 | Methylcrotonoyl-CoA carboxylase 2 (beta) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
MAP1B | Microtubule-associated protein 1B | Plasma proteins
| | | | | Tissue enhanced |
TNPO1 | Transportin 1 | Plasma proteins
| | | | | Expressed in all |
FCHO2 | FCH domain only 2 | | | | | | Expressed in all |
TMEM174 | Transmembrane protein 174 | Predicted membrane proteins
| | | | | Tissue enriched |
BTF3 | Basic transcription factor 3 | Plasma proteins
| | | | | Expressed in all |
ARHGEF28 | Rho guanine nucleotide exchange factor (GEF) 28 | | | | | | Mixed |
HEXB | Hexosaminidase B (beta polypeptide) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
FAM169A | Family with sequence similarity 169, member A | | | | | | Tissue enhanced |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
COL4A3BP | Collagen, type IV, alpha 3 (Goodpasture antigen) binding protein | | | | | | Expressed in all |
PDE8B | Phosphodiesterase 8B | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enriched |
TBCA | Tubulin folding cofactor A | | | | | | Expressed in all |
ARSB | Arylsulfatase B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
DMGDH | Dimethylglycine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
BHMT2 | Betaine--homocysteine S-methyltransferase 2 | Cancer-related genes Enzymes
| | | | | Group enriched |
BHMT | Betaine--homocysteine S-methyltransferase | Enzymes Plasma proteins
| | | | | Group enriched |
HOMER1 | Homer homolog 1 (Drosophila) | | | | | | Tissue enhanced |
MTX3 | Metaxin 3 | Mitochondrial proteins
| | | | | Mixed |
SERINC5 | Serine incorporator 5 | Predicted membrane proteins
| | | | | Expressed in all |
ZFYVE16 | Zinc finger, FYVE domain containing 16 | | | | | | Expressed in all |
RASGRF2 | Ras protein-specific guanine nucleotide-releasing factor 2 | RAS pathway related proteins
| | | | | Mixed |
CKMT2 | Creatine kinase, mitochondrial 2 (sarcomeric) | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Group enriched |
ACOT12 | Acyl-CoA thioesterase 12 | Enzymes Transporters
| | | | | Tissue enriched |
RPS23 | Ribosomal protein S23 | Ribosomal proteins
| | | | | Expressed in all |
XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | Cancer-related genes
| | | | | Mixed |
VCAN | Versican | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HAPLN1 | Hyaluronan and proteoglycan link protein 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
COX7C | Cytochrome c oxidase subunit VIIc | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
MEF2C | Myocyte enhancer factor 2C | Disease related genes Transcription factors
| | | | | Expressed in all |
POLR3G | Polymerase (RNA) III (DNA directed) polypeptide G (32kD) | RNA polymerase related proteins
| | | | | Mixed |
ERAP1 | Endoplasmic reticulum aminopeptidase 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CTD-2260A17.2 | Uncharacterized protein | | | | | | Tissue enhanced |
ERAP2 | Endoplasmic reticulum aminopeptidase 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CHD1 | Chromodomain helicase DNA binding protein 1 | Enzymes FDA approved drug targets
| | | | | Expressed in all |